Table 12 Pharmacokinetics results
From: Preparation and in vitro evaluation of BBG-250 loaded liposomal formulation for anticancer potential
Sl No | Compound name | GI absorpti- on | BBB perme -ant | CYP1 A2 inhibit -or | CYP2 C19 inhibit- or | CYP2 C9 inhibit -or | CYP2 D6 inhibi t-or | CYP3 A4 inhibi t-or |
|---|---|---|---|---|---|---|---|---|
1 | BBG-250 | Low | No | No | No | No | No | No |
2 | Docetaxel | Low | No | No | No | No | No | Yes |